Literature DB >> 11166621

Cure of undifferentiated small cell carcinoma of the urinary bladder with M-VAC chemotherapy.

R J. Nejat1, R Purohit, E T. Goluboff, D Petrylak, M A. Rubin, M C. Benson.   

Abstract

Small cell carcinoma (SCC) of the urinary bladder is a rare, aggressive malignancy with approximately 135 cases reported in the literature. Treatments have included chemotherapy, radical surgery, radiotherapy, and combinations of these. We present the apparent cure of a 73-year-old man who presented with clinical stage T2 SCC of the urinary bladder. He was treated with three cycles of methotrexate, vinblastine, Adriamycin (doxorubicin), and cisplatin (M-VAC) chemotherapy. Subsequent radical cystoprostatectomy revealed no pathologic evidence of tumor. The patient is alive and well with no evidence of recurrence 3 years post cystectomy. A brief review of the literature is also presented.

Entities:  

Year:  2001        PMID: 11166621     DOI: 10.1016/s1078-1439(00)00098-3

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  4 in total

1.  Primary small cell neuroendocrine carcinoma of urinary bladder: an uncommon entity to be recognized.

Authors:  G Nabi; I Singh; M S Ansari; M C Sharma; P N Dogra
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

Review 2.  Neuroendocrine Tumors of the Urinary Bladder According to the 2016 World Health Organization Classification: Molecular and Clinical Characteristics.

Authors:  Erik Kouba; Liang Cheng
Journal:  Endocr Pathol       Date:  2016-09       Impact factor: 3.943

3.  Small cell carcinoma of the urinary bladder: A case report and review of the literature.

Authors:  Wen-Ting Ou; Qi-Lian Liang; Xin Huang; Zhou-Yu Li; Qiu-Long Liu
Journal:  Oncol Lett       Date:  2014-10-30       Impact factor: 2.967

4.  Small cell carcinoma of the urinary bladder: CT and MR imaging findings.

Authors:  Jong Chul Kim; Kie Hwan Kim; Seungeun Jung
Journal:  Korean J Radiol       Date:  2003 Apr-Jun       Impact factor: 3.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.